Hosokawa Micron’s Mini Cyclomix lab mixer is designed to blend formulations for dry-powder inhalers without deteriorating the particles.
Hosokawa Micron’s Mini Cyclomix lab mixer is designed to blend formulations for dry-powder inhalers (DPIs) without deteriorating the particles. The mixer features exchangeable product bowl sizes of 100 mL, 1 L, and 2 L, which require no special tools to be connected to the drive unit with a bayonet ring.
An integrated touch panel operates the unit, with recipe management, data logging, and data export controls. An adjustable mixing speed and time allows the mixer to be used for coating, bonding, rounding, or densification. A combination of impact and shear mixing is used, via an agitator with paddles and knife blade. When the rotational movement moves the product to the top of the vessel, a formed dome at the top of the mixer pushes the product back down through the center of the vessel, ensuring a thorough mixing process.
Hosokawa Micron www.hosokawa.co.uk
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.